Tackling the increasing complexity of CF care.
Health outcomes for individuals with cystic fibrosis (CF) have dramatically improved in parallel with better organization of clinical care systems, evolution of novel therapeutics, and improvements in diagnosis and screening for CF and CF-related complications. In parallel with these advances has come an increasing complexity and burden of care, leading to challenges with adherence to treatment regimens. As novel therapeutics continue to be developed and introduced to the CF care regimen, there are clear opportunities to refine and personalize care. This can be done by adding comparative effectiveness research to the CF clinical research paradigm and integrating novel technologies in drug delivery and remote monitoring that can facilitate adherence but also reduce the burden of treatment while maintaining efficacy. This review highlights both the challenges of the increasingly complex treatment regimens in CF and the opportunities to advance care by addressing adherence, implementation science, comparative effectiveness, and integration of novel technologies in CF care.
Division of Respiratory Diseases, Boston Children's Hospital, Boston, Massachusetts.
Gregory S
GS
Sawicki
Division of Pulmonary Medicine, Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington.
Christopher H
CH
Goss
D035843:Biomedical Research; D057186:Comparative Effectiveness Research; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000628:therapy; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D006297:Health Services Accessibility; D006801:Humans; D010349:Patient Compliance; D012107:Research Design; D016896:Treatment Outcome
C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator
adherence; comparative effectiveness research; implementation research; treatment burden; treatment complexity